Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 2Recruiting 2Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 1330Neoplasms 984Carcinoma, Non-Small-Cell Lung 860Prostatic Neoplasms 728Colorectal Neoplasms 665Lung Neoplasms 551Leukemia, Myeloid, Acute 476Neoplasm Metastasis 435Pancreatic Neoplasms 418Carcinoma, Hepatocellular 408Multiple Myeloma 396Ovarian Neoplasms 391Stomach Neoplasms 380Recurrence 364Squamous Cell Carcinoma of Head and Neck 324Melanoma 294Brain Neoplasms 289Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 273Glioblastoma 265Head and Neck Neoplasms 264Precursor Cell Lymphoblastic Leukemia-Lymphoma 255Endometrial Neoplasms 233Lymphoma 228Rectal Neoplasms 223Esophageal Neoplasms 222Sarcoma 214Carcinoma, Renal Cell 204Colonic Neoplasms 194Lymphoma, Non-Hodgkin 191

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Safety Issues × Clear all
NCT05142592 2025-09-24

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Nanjing Immunophage Biotech Co., Ltd

Phase 1/2 Recruiting
196 enrolled

Safety Issues

NCT06509490 2024-07-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Recruiting
9 enrolled

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon âš¡